Analysed BridgeBio Pharma Inc (BBIO:NASDAQ) News Sources
Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating
Yahoo Finance UK
BridgeBio Pharma (BBIO) Achieves Record 2025 Revenue Driven by Attruby Commercial Success
Yahoo Finance
BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference
Yahoo Finance UK
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), BridgeBio Pharma (BBIO) and Establishment Labs Holdings (ESTA)
The Globe and Mail
BioMarin Pharmaceutical Inc. (BMRN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Seeking Alpha
What is the current price of BridgeBio Pharma Inc (BBIO:NASDAQ)?
The current price of BridgeBio Pharma Inc (BBIO:NASDAQ) is $65.36.
BridgeBio Pharma Inc (BBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of BridgeBio Pharma Inc (BBIO:NASDAQ) since the previous trading day is $-0.81.
BridgeBio Pharma Inc (BBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of BridgeBio Pharma Inc (BBIO:NASDAQ) since the previous trading day is -1.22%.
What is This Week's average sentiment score for BridgeBio Pharma Inc (BBIO:NASDAQ)?
This Week's average sentiment score for BridgeBio Pharma Inc (BBIO:NASDAQ) is 83 out of 100.
What is This Week's average sentiment for BridgeBio Pharma Inc (BBIO:NASDAQ)?
This Week's sentiment for BridgeBio Pharma Inc (BBIO:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.